Inventor · disambiguated record
Laurent Lariviere
Also filed as: LARIVIERE LAURENT
15 granted patents·7 pending applications·34 citations·filing 2016–2025
89Inventor score
Files withHOFFMANN LA ROCHE22
Top patents by PatentIndex Score
22 records- 0195US11286300B2Humanized anti-human CD19 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Mar 29, 2022·11 cites·8 claims
- 0295US10941205B2Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Granted Mar 9, 2021·10 cites·13 claims
- 0391US11603411B2Bispecific anti-human CD20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Granted Mar 14, 2023·9 cites·5 claims
- 0490US12030952B2Bispecific anti-human CD20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted Jul 9, 2024·1 cites·10 claims
- 0588US11787868B2Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Oct 17, 2023·1 cites·5 claims
- 0685US2025297025A1Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0783US2023365702A1Bispecific anti-human a-beta/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0882US2025376523A1Humanized anti-human cd19 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0982US2024317879A1Bispecific anti-human cd20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1081US12358997B1Bispecific anti-human A-beta/anti-human transferrin receptor antibodiesHOFFMANN LA ROCHE·Filed 2025·Granted Jul 15, 2025·0 cites·2 claims
- 1181US12129306B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2023·Granted Oct 29, 2024·0 cites·1 claims
- 1281US11668722B2Antibody selection methodHOFFMANN LA ROCHE·Filed 2019·Granted Jun 6, 2023·1 cites·7 claims
- 1381US11180571B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2019·Granted Nov 23, 2021·1 cites·31 claims
- 1476US12215152B2Humanized anti-human CD19 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted Feb 4, 2025·0 cites·8 claims
- 1575US11685790B2Antibodies binding to STEAP-1HOFFMANN LA ROCHE·Filed 2021·Granted Jun 27, 2023·0 cites·1 claims
- 1673US12487245B2Antibody selection methodHOFFMANN LA ROCHE·Filed 2023·Granted Dec 2, 2025·0 cites·7 claims
- 1765US2020216554A1Bispecific anti-human cd20/human transferrin receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1863US11440942B2Complement factor based affinity chromatographyHOFFMANN LA ROCHE·Filed 2019·Granted Sep 13, 2022·0 cites·12 claims
- 1961US12258371B2Stabilized immunoglobulin domainsHOFFMANN LA ROCHE·Filed 2020·Granted Mar 25, 2025·0 cites·10 claims
- 2061US2025093367A1Quantification of low amounts of antibody side-productsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2148US12497434B2IL-37 fusion proteins and uses thereofHOFFMANN LA ROCHE·Filed 2020·Granted Dec 16, 2025·0 cites·16 claims
- 2246US2020354457A1Bispecific antibodies comprising an antigen-binding site binding to lag3HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurent Lariviere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →